Can We Increase the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutics?

Researchers have identified small molecules that increase the ability of chemotherapeutic agents to kill pancreatic cancer cells and slow tumor growth in mice, according to the February issue of Gastroenterology. One way that chemotherapeutics such gemcitabine, 5-fluorouracil, and platinum-based compounds kill cancer cells is by causing tumor suppressor proteins to

Read more

Does Menopause Affect Outcomes from Roux-en-Y Gastric Bypass Surgery?

Estradiol increases body weight loss and satiation effects of Roux-en-Y gastric bypass (RYGB) in ovariectomized rats, according to the August issue of Gastroenterology. Approximately ~85% of bariatric surgery procedures are performed on women, but little is known about the effects of menopause or reproductive hormones, such as estrogen, on outcomes.

Read more

Successful Surgery for Children with Chronic Pancreatitis

Total pancreatectomy, accompanied by auto-transplantation of islet cells, increases the quality of life for children with severe chronic pancreatitis, according to Melena Bellin et al. in the September issue of Clinical Gastroenterology and Hepatology. Chronic pancreatitis is rare among children, but is painful and progressive and can lead to narcotic

Read more

New Treatment for IBS

LX1031, a drug that inhibits serotonin production, relieves symptoms and increases stool consistency in patients with nonconstipating irritable bowel syndrome (IBS), according to a study by Philip Brown et al. in the August issue of Gastroenterology. Serotonin (also called 5-hydroxytryptamine or 5-HT) is a neurotransmitter that controls mood and cognition, as

Read more

Certolizumab and Remission in Some Patients With Crohn’s Disease

The drug certolizumab pegol induces remission in patients with Crohn’s disease who have high baseline levels of inflammation, according to William Sandborn et al. in the August issue of Clinical Gastroenterology and Hepatology. Patients with moderate to severe Crohn’s disease that do not respond conventional therapy are often treated with

Read more

Tracking Crohn’s Therapy

Measuring blood levels of C-reactive protein (CRP), a marker of inflammation, is a good way to monitor recovery from Crohn’s disease (CD) in patients being treated with infliximab, according to Matthias Jürgens et al. in the May issue of Clinical Gastroenterology and Hepatology. CRP is a protein released into the blood

Read more